Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism CB1 agonists(Cannabinoid CB1 receptor agonists), PPARα agonists(Peroxisome proliferator-activated receptor α agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Idiopathic Pulmonary Fibrosis | Preclinical | US | 01 Jul 2024 |